Osteoporosis Drugs Market in BRIC Nations 2015-2019 Size and Share Published in 2015-09-16 Available for US$ 2500 at Researchmoz.us
Description
About osteoporosis
Osteoporosis, or porous bone, is a disease characterised by low bone density and structural deterioration of bone tissue, leading to fragile bones. This increases the risk of fractures. Osteoporosis mainly affects women, but can also affect men. In women, bone loss occurs very rapidly in the first few years after menopause and continues through the postmenopausal stage. Osteoporosis progresses when bone resorption occurs too quickly or when replacement occurs too slowly. Risk factors for osteoporosis that cannot be controlled include gender, age, body size (low body weight), ethnicity, and family history. Risk factors that can be controlled include sex hormones, medication use, calcium and vitamin intake, alcohol intake, and smoking.
Technavio’s analysts forecast the osteoporosis drugs market in BRIC nations to grow at a CAGR of 17.43% over the period 2014-2019.
Covered in this report
This report covers the present scenario and the growth prospects of the osteoporosis drugs market in BRIC nations for the period 20152019. To calculate the market size, the report considers revenue generated from the sales of various pharmaceutical products used in the treatment of osteoporosis. Pharmaceutical products are classified as branded and generic drugs.
Technavio’s report, Osteoporosis Drugs Market in BRIC Nations 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers Brazil, Russia, India, and China; it also covers the landscape of the osteoporosis drugs market in BRIC nations and its growth prospects in the coming years. The report includes a discussion on the key vendors operating in this market.
Key countries
Brazil
China
India
Russia
Get a Sample Copy of the Report: http://www.researchmoz.us/enquiry.php?type=S&repid=363332
Key vendors
Amgen
Eli Lilly
Merck
Novartis
Other prominent vendors
Abiogen Pharma
Deltanoid Pharmaceuticals
F. Hoffmann La Roche
GlaxoSmithKline
IMMD
Ligand Pharmaceuticals
Pantarhei Bioscience
Pfizer
PhytoHealth
Radius Health
UPSHER-SMITH LABORATORIES
Zosano Pharma
Market driver
Increase in aging population
For a full, detailed list, view our report
Market challenge
Multiple patent expiries
For a full, detailed list, view our report
Market trend
Shift toward anabolic treatments
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Inquiry on this report: http://www.researchmoz.us/enquiry.php?type=E&repid=363332
Table of Content
PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Osteoporosis: An overview
Understanding osteoporosis
Epidemiology and demography
Risk factors
Symptoms
Diagnosis
Treatment
PART 06: Market landscape
Market overview
Market size and forecast
Five forces analysis
Browse All Pharmaceutical Market Research Reports at: http://www.researchmoz.us/pharmaceutical-market-reports-38.html
About ResearchMoz
ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives.
Contact Us:
ResearchMoz
Mr. Nachiket Ghumare, +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
sales@researchmoz.us
http://www.researchmoz.us/